For more than four decades, Michael H. Cohen has advised healthcare providers, entrepreneurs, and organizations on navigating complex regulatory frameworks, structuring compliant business models, and managing legal risk in a rapidly evolving healthcare landscape. His practice focuses on helping clients align innovation with regulatory requirements across a wide range of healthcare and life sciences sectors.
Michael works with healthcare professionals, startups, and established companies on transactional, compliance, and strategic matters involving healthcare delivery, technology, and emerging modalities. He brings a practical understanding of how regulatory structures impact business operations, informed by decades of experience counseling clients and resolving high-stakes disputes.
In addition to his legal practice, Michael has served in academic and research roles that shaped national conversations around healthcare law and policy. He held faculty appointments at Harvard Medical School and the Harvard T.H. Chan School of Public Health, where he developed policies and procedures for integrative medicine across multiple affiliated hospitals and led interdisciplinary research initiatives supported by national grant funding. His work has addressed legal and ethical considerations in healthcare innovation, complementary and alternative medicine, and patient care delivery.
Michael has authored multiple books and more than 100 articles published in peer-reviewed medical journals and leading legal publications. He also has delivered lectures at academic institutions and professional conferences throughout the United States and internationally.
Independent of Offit Kurman, Michael also serves as a healthcare arbitrator and mediator through Healthcare ADR Inc., on the panels of the American Arbitration Association (AAA), the World Intellectual Property Organization (WIPO), the American Health Lawyers Association (AHLA) Dispute Resolution Service, and National Arbitration and Mediation (NAM). As an attorney who arbitrates complex, multi-million-dollar healthcare legal disputes, Michael understands firsthand how regulatory and structural vulnerabilities can translate into litigation, giving the transactional and compliance counsel he helps bring to clients a dimension that few regulatory attorneys can offer.
Areas of Focus:
- Healthcare Corporate and Commercial
Advises healthcare providers and organizations on healthcare transactions, including mergers and acquisitions, affiliations, and clinical integration arrangements. Counsels clients on healthcare contracts and regulatory compliance involving physician employment agreements, joint ventures, and vendor relationships, with a focus on aligning business objectives with healthcare regulatory requirements. - Healthcare Data Privacy and Security
Counsels healthcare providers, business associates, and health technology companies on HIPAA compliance, HITECH requirements, and healthcare data privacy laws. Advises on data breach response, risk mitigation, and Business Associate Agreements to ensure regulatory compliance and protection of sensitive health information. - Anti-Kickback Statute and Stark Law Compliance
Advises healthcare organizations on fraud and abuse laws, including the Anti-Kickback Statute and Stark Law. Structures physician compensation and referral arrangements to meet regulatory safe harbors and exceptions, while conducting compliance reviews to mitigate enforcement risk. - Corporate Practice of Medicine and MSO Structuring
Guides healthcare providers, investors, and management services organizations (MSOs) on corporate practice of medicine laws and compliant business structuring. Drafts and negotiates MSO agreements and management arrangements across multiple states, supporting regulatory compliance and operational efficiency. - Telemedicine and Digital and Mobile Health
Advises telemedicine companies and digital health platforms on multi-state regulatory compliance, including licensure, prescribing, and reimbursement requirements. Counsels health technology developers on FDA, FTC, and state regulatory frameworks impacting digital health and innovation. - Emerging Healthcare Modalities
Counsels emerging healthcare businesses including integrative medicine, medical spas, and telehealth venture, on regulatory compliance, licensing, and corporate structure. Advises on healthcare innovation in areas such as regenerative medicine, wellness services, and non-traditional care delivery models. - FDA and FTC Regulatory Matters
Advises life sciences and consumer health companies on FDA and FTC regulatory compliance, including labeling, marketing, and claims substantiation. Counsels on advertising standards, product classification, and enforcement risk across pharmaceuticals, medical devices, and dietary supplements. - Healthcare Regulatory Compliance
Provides healthcare regulatory counsel on federal and state laws, including HIPAA, Stark Law, and Anti-Kickback requirements. Conducts compliance assessments and risk analyses to help healthcare organizations identify vulnerabilities and maintain regulatory compliance. - Academic and Research Contributions to Healthcare Law
Brings a strong foundation in healthcare law and policy through academic research, publications, and teaching. Contributed to national and international discussions on healthcare regulation and innovation through peer-reviewed scholarship, grant-funded research, and presentations at leading academic and professional institutions.
- University of California, Berkeley, School of Law (J.D.)
- University of California, Berkeley, Haas School of Business (M.B.A)
- University of Iowa, Iowa Writers' Workshop (M.F.A.)
- Columbia University, Columbia College (B.A.)
- French – conversational
- Hebrew – conversational
- Spanish – conversational
- Invited Faculty, Medical Institute for Law Faculty, Cleveland Clinic / Cleveland-Marshall School of Law (1995)
- G. Joseph Tauro Distinguished Scholar, Boston University School of Law (1984)
- CJS Award; Am. Jur. Award, Boston University School of Law (1984)
- Invited to Law Review, Boston University School of Law (1984)
- Invited to Law Review, UC Berkeley School of Law (1984)
- M.D. Anderson Cancer Center Integrative Medicine Program / NCI, Consultant (2005)
- The Epilepsy Foundation: Asian Herbal Products for Epilepsy, Co-Investigator (2004–2005)
- Hospital for Sick Children Foundation (Toronto): Decision-Making About Complementary and Alternative Therapies for Children and Youth, Research Collaborator (2004–2005)
- The Greenwall Foundation: Pediatric Use of Complementary Therapies by Parents: Ethical and Policy Choices, Principal Investigator (2004–2005)
- NIH/NCCAM: International Center for Research on Complementary and Alternative Medicine, Co-Investigator (2003–2005)
- NIH/National Library of Medicine: Legal and Social Barriers to Alternative Therapies, Principal Investigator (2002–2005)
- Ministry of Science and Research of North Rhine-Westphalia, Germany: Governmental Regulations for Traditional Chinese Herbal Medicine, Consultant (2004)
- American Specialty Health Plan: Credentialing Practices, Malpractice Liability Policies, and Guidelines Governing Recommendations Involving Dietary Supplements, Principal Investigator (2000–2002)
- NIH/NCCAM: Models of Integrative Care in an Academic Health Center, Co-Investigator (2000–2002)
- Medtronic Foundation: Credentialing, Liability and Dietary Supplements Policies, Co-Investigator (2000–2002)
- California
- District of Columbia
- Massachusetts
- Nevada
- New York
- Arbitration Panel Member, American Health Lawyers Association (AHLA) Dispute Resolution Service, (2022–Present)
- Faculty, The Leadership Program in Integrative Healthcare at Duke University (2014)
- Advisory Board Member, Integrative Pediatrics Council (2006)
- External Advisory Committee, University of Texas M.D. Anderson Cancer Center, Integrative Medicine (2005)
- Board Member, Society of Integrative Oncology (2005)
- Core Faculty Member, Asian Medicine and Healing Program, Harvard Medical School Osher Institute (2005)
- External Reviewer: Pediatrics; Journal of Law and Religion; Alternative Therapies in Health and Medicine; Medical Journal of Australia; American Journal of Law, Medicine and Ethics; University of Michigan Press (2000–2005)
- Editorial Board, Integrative Medicine: A Clinician's Journal (2004)
- National Advisory Board, Corporate Health Improvement Program, University of Arizona School of Medicine (2004)
- Consultant, Institute of Medicine, National Academy of Sciences, Committee on Complementary and Alternative Medicine Use by the American Public (2003–2004)
- Advised on the work of the Massachusetts Special Commission on Complementary and Alternative Medical Practitioners (2002–2003)
- Advised on the Federation of State Medical Boards Model Guidelines for Complementary and Alternative Therapies (2000–2002)
- Research Advisory Council, Religion, Health and Healing Initiative, Harvard Divinity School (2001–2002)
- Advisor to Dr. Eisenberg, Federation of State Medical Boards, Model Guidelines for Complementary and Alternative Therapies (2000–2002)
- Legal Editor, Alternative Healthcare Management (1998–1999)
- Co-Editor, Legal Matters, Alternative and Complementary Therapies (1995–1996)
- Member, American Health Lawyers Association
